RYLPF (Koninklijke Philips NV) Moat Score: 6/10 (As of Jun. 24, 2026)


RYLPF Koninklijke Philips NV RYLPF
73 GF Score
Price $26.19
GF Value $25.13
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Moat Score?

Koninklijke Philips NV RYLPF 73 Moat Score is 6 as of Jun. 24, 2026. GuruFocus rates RYLPF with a GF Score™ of 73/100 and a GF Value™ of $25.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 95.74% on this metric.

Koninklijke Philips NV has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Koninklijke Philips NV has Narrow Moat: Philips has a strong narrow moat due to its valuable intellectual property, strong brand strength, and economies of scale in healthcare technology. Its innovation and R&D capabilities support its market leadership, but competitive pressures prevent a wide moat classification.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Koninklijke Philips NV might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Koninklijke Philips NV  (OTCPK:RYLPF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Koninklijke Philips NV Moat Score Related Terms

RYLPF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Koninklijke Philips NV's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Koninklijke Philips NV Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Moat Score distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's Moat Score falls into.


RYLPF
73GF Score
Koninklijke Philips NV RYLPF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Koninklijke Philips NV (RYLPF) has a Moat Score of 6 as of Jun. 24, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Koninklijke Philips NV ranks #36 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Koninklijke Philips NV's Moat Score too high?
Koninklijke Philips NV's current Moat Score is 6. Based on the distribution chart, Koninklijke Philips NV ranks #36 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Koninklijke Philips NV has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #36 out of 846 companies for Moat Score. This places Koninklijke Philips NV in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Koninklijke Philips NV's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.13, compared to a current price of $26.19 — trading 4.2% above its estimated fair value. The current Moat Score is 6. Koninklijke Philips NV's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Moat Score is 6 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of $26.19 is trading 4.2% above its estimated GF Value™ of $25.13. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for RYLPF:

  • Moat Score: 6
  • GF Value™: $25.13 vs. price of $26.19 (4.2% above fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
73GF Score

Get the complete analysis for RYLPF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.19
Price
$25.13
GF Value